PortfoliosLab logoPortfoliosLab logo
OKUR vs. TARA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OKUR vs. TARA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in OnKure Therapeutics, Inc (OKUR) and Protara Therapeutics, Inc. (TARA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OKUR achieves a 44.83% return, which is significantly higher than TARA's -20.83% return.


OKUR

1D
-0.47%
1M
-8.70%
YTD
44.83%
6M
60.31%
1Y
56.13%
3Y*
5Y*
10Y*

TARA

1D
-2.76%
1M
-22.57%
YTD
-20.83%
6M
-37.94%
1Y
28.66%
3Y*
13.32%
5Y*
-16.16%
10Y*
-33.11%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OKUR vs. TARA - Yearly Performance Comparison


2026 (YTD)20252024
OKUR
OnKure Therapeutics, Inc
44.83%-66.28%-53.89%
TARA
Protara Therapeutics, Inc.
-20.83%0.95%200.00%

Correlation

The correlation between OKUR and TARA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Oct 8, 2024

0.23

Fundamentals

Market Cap

OKUR:

$57.43M

TARA:

$242.81M

EPS

OKUR:

-$3.22

TARA:

-$1.35

PB Ratio

OKUR:

0.31

TARA:

1.34

Total Revenue (TTM)

OKUR:

$0.00

TARA:

$0.00

Gross Profit (TTM)

OKUR:

-$202.00K

TARA:

-$181.00K

EBITDA (TTM)

OKUR:

-$60.95M

TARA:

-$66.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


OnKure Therapeutics, Inc

Protara Therapeutics, Inc.

Often compared with TARA:
TARA vs. GNLX

Return for Risk

OKUR vs. TARA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OKUR
OKUR Risk / Return Rank: 6666
Overall Rank
OKUR Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
OKUR Sortino Ratio Rank: 6868
Sortino Ratio Rank
OKUR Omega Ratio Rank: 6363
Omega Ratio Rank
OKUR Calmar Ratio Rank: 6868
Calmar Ratio Rank
OKUR Martin Ratio Rank: 6868
Martin Ratio Rank

TARA
TARA Risk / Return Rank: 5656
Overall Rank
TARA Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
TARA Sortino Ratio Rank: 5757
Sortino Ratio Rank
TARA Omega Ratio Rank: 5656
Omega Ratio Rank
TARA Calmar Ratio Rank: 5555
Calmar Ratio Rank
TARA Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OKUR vs. TARA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for OnKure Therapeutics, Inc (OKUR) and Protara Therapeutics, Inc. (TARA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OKURTARADifference

Sharpe ratio

Return per unit of total volatility

0.76

0.36

+0.40

Sortino ratio

Return per unit of downside risk

1.60

1.13

+0.47

Omega ratio

Gain probability vs. loss probability

1.18

1.14

+0.04

Calmar ratio

Return relative to maximum drawdown

1.36

0.65

+0.71

Martin ratio

Return relative to average drawdown

3.11

1.39

+1.71

OKUR vs. TARA - Sharpe Ratio Comparison

The current OKUR Sharpe Ratio is 0.76, which is higher than the TARA Sharpe Ratio of 0.36. The chart below compares the historical Sharpe Ratios of OKUR and TARA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OKURTARADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.76

0.36

+0.40

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.36

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.81

-0.37

-0.44

Drawdowns

OKUR vs. TARA - Drawdown Comparison

The maximum OKUR drawdown since its inception was -90.47%, smaller than the maximum TARA drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for OKUR and TARA.


Loading charts...

Drawdown Indicators


OKURTARADifference

Max Drawdown

Largest peak-to-trough decline

-90.47%

-99.86%

+9.39%

Max Drawdown (1Y)

Largest decline over 1 year

-41.56%

-44.18%

+2.62%

Max Drawdown (3Y)

Largest decline over 3 years

-66.46%

Max Drawdown (5Y)

Largest decline over 5 years

-89.53%

Max Drawdown (10Y)

Largest decline over 10 years

-99.75%

Current Drawdown

Current decline from peak

-78.14%

-99.47%

+21.33%

Average Drawdown

Average peak-to-trough decline

-73.50%

-85.09%

+11.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.12%

20.61%

-2.49%

Volatility

OKUR vs. TARA - Volatility Comparison

OnKure Therapeutics, Inc (OKUR) has a higher volatility of 25.72% compared to Protara Therapeutics, Inc. (TARA) at 18.75%. This indicates that OKUR's price experiences larger fluctuations and is considered to be riskier than TARA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OKURTARADifference

Volatility (1M)

Calculated over the trailing 1-month period

25.72%

18.75%

+6.97%

Volatility (6M)

Calculated over the trailing 6-month period

56.77%

58.25%

-1.48%

Volatility (1Y)

Calculated over the trailing 1-year period

74.32%

79.90%

-5.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.84%

81.03%

-7.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.84%

91.24%

-17.40%

Dividends

OKUR vs. TARA - Dividend Comparison

Neither OKUR nor TARA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OKUR vs. TARA - Financials Comparison

This section allows you to compare key financial metrics between OnKure Therapeutics, Inc and Protara Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober202600
(OKUR) Total Revenue
(TARA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


OKUR and TARA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OKUR has higher volatility (25.72%) compared to TARA (18.75%). In terms of maximum drawdown, OKUR dropped -90.47% vs TARA's -99.86%.

OKUR currently has the higher Sharpe Ratio (0.76 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OKUR and TARA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer